aprN Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Function

Antibodies (immunoglobulins) are Y-shaped proteins composed of four polypeptide chains: two identical heavy chains (~50 kDa each) and two identical light chains (~25 kDa each) . These chains are linked via disulfide bonds, forming two antigen-binding sites (Fabs) and a constant region (Fc) that mediates effector functions.

ComponentDescriptionRole
Heavy ChainsDetermine antibody isotype (e.g., IgG, IgA)Dictate effector functions (e.g., complement activation)
Light ChainsContribute to antigen recognitionCan be either κ or λ type (no functional difference)
Variable (V) RegionsHypervariable sequences at amino terminiBind specific epitopes on antigens
Constant (C) RegionsConserved sequencesInteract with immune cells (e.g., Fc receptors)

IgG Antibody Characteristics

IgG is the most abundant antibody isotype in human serum, with a molecular weight of ~150 kDa . Its structure includes:

  • Two Fab fragments: Each contains paired V regions (V_H and V_L) for antigen binding.

  • One Fc fragment: Composed of the C-terminal domains of heavy chains, enabling interactions with Fc receptors and the complement system.

Key Properties

  • Hinge region: Confers flexibility between Fab and Fc fragments.

  • Cross-linking: Bivalent binding enhances antigen retention (e.g., agglutination of pathogens) .

  • Subclasses: IgG1–4 differ in Fc-mediated functions (e.g., IgG1 strongly activates complement) .

COVID-19 Antibody Responses

Recent studies highlight antibody dynamics in SARS-CoV-2 infection:

  • Early IgM and IgA responses: Detectable within days post-infection but wane over time .

  • Persistent IgG responses: Correlate with long-term immunity and vaccine efficacy .

Antigen TargetAntibody TypeClinical Correlation
Spike (S1/S2)IgG, IgANeutralizing activity
RBDIgGHigher levels linked to survival
Nucleocapsid (NP)IgM, IgG, IgADivergent profiles in severe vs. mild cases

Therapeutic Applications

Engineered antibody fragments, such as single-chain Fv (scFv), are being explored for targeted therapies. These molecules combine V_H and V_L domains via synthetic linkers, enabling tissue penetration and toxin conjugation (e.g., immunotoxins for cancer) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (12-14 weeks)
Synonyms
Subtilisin NAT (EC 3.4.21.62) (Nattokinase), aprN
Target Names
aprN
Uniprot No.

Target Background

Function
Subtilisin is an extracellular alkaline serine protease that catalyzes the hydrolysis of proteins and peptide amides. Subtilisin NAT also exhibits fibrinolytic activity.
Protein Families
Peptidase S8 family
Subcellular Location
Secreted.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.